Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Recession Coverage Without Emdogain

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 4 (2)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06250088Phase 4Unknown

Emdogain Adjunctive to Autotransplantation

NCT02230787Phase 4Completed

Gingival Recession Coverage With and Without Emdogain

Showing all 2 trials

Research Network

Common Treatments

  • Recession Coverage Without Emdogain1
  • Emdogain Emd Test1
  • Recession Coverage With Emdogain1
  • Sham Group1

Active Sponsors

  • Universidad Complutense de Madrid1
  • University of Bern1

Top Investigators

Related Conditions

  • Enamel Matrix Derivatives1
  • Autotransplantation1
  • Gingival Recession1
  • Autologous Transplantation1

Activity Timeline